Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 5841 S. Maryland Ave., MC 3077, Chicago, IL 60637, USA.
Pharmacol Biochem Behav. 2012 Oct;102(4):526-31. doi: 10.1016/j.pbb.2012.06.016. Epub 2012 Jun 29.
Preclinical studies suggest that cost/benefit decision-making involves interactions between adenosine and dopamine (DA). In rats, DA depletion decreases willingness to incur effort costs, while adenosine antagonism reverses these effects, likely by increasing DA transmission. Caffeine is a non-selective adenosine antagonist commonly used to facilitate effortful tasks, and thus may affect decisions involving effort costs in humans. The current study examined acute effects of 200 mg of caffeine on willingness to exert effort for monetary rewards at varying levels of reward value and reward probability, in young adult light caffeine users. Based on previous findings with amphetamine, we predicted that caffeine would increase willingness to exert effort. At separate sessions, 23 healthy normal adults received placebo or 200 mg caffeine under counterbalanced double-blind conditions, then completed the effort expenditure for rewards task (EEfRT). Measures of subjective and cardiovascular effects were obtained at regular intervals. Caffeine produced small but significant subjective and cardiovascular effects, and sped psychomotor performance on the EEfRT. Caffeine did not alter willingness to exert effort, except in high cardiovascular responders to caffeine, in whom it decreased willingness to exert effort. These results were contrary to our predictions, but consistent with rodent studies suggesting that moderate doses of caffeine alone do not affect effort, but rather only influence effort in the context of DA antagonism. Our results demonstrate that psychomotor speeding and decisional effects on the EEfRT are dissociable, providing additional evidence for the EEfRT as a specific measure of effort-based decision-making. This study provides a starting point for exploring contributions of the adenosine system to motivation in humans.
临床前研究表明,成本/效益决策涉及腺苷和多巴胺 (DA) 之间的相互作用。在大鼠中,DA 耗竭会降低付出努力的意愿,而腺苷拮抗作用则会逆转这些影响,可能是通过增加 DA 传递。咖啡因是一种非选择性的腺苷拮抗剂,常用于促进费力的任务,因此可能会影响涉及人类努力成本的决策。本研究在年轻成年轻度咖啡因使用者中,考察了 200mg 咖啡因对不同奖励价值和奖励概率下为金钱奖励付出努力的意愿的急性影响。基于安非他命的先前发现,我们预测咖啡因会增加付出努力的意愿。在单独的会议上,23 名健康的正常成年人在双盲条件下接受安慰剂或 200mg 咖啡因,然后完成努力支出获得奖励任务 (EEfRT)。定期测量主观和心血管效应的措施。咖啡因产生了微小但显著的主观和心血管效应,并加速了 EEFRT 上的精神运动表现。咖啡因并没有改变付出努力的意愿,除了对咖啡因有高心血管反应的人,他们的付出努力的意愿降低了。这些结果与我们的预测相反,但与啮齿动物研究一致,即单独给予中等剂量的咖啡因不会影响努力,而是只会在 DA 拮抗的情况下影响努力。我们的结果表明,EEfRT 上的精神运动加速和决策效应是可分离的,为 EEFRT 作为努力决策的特定测量提供了额外的证据。这项研究为探索人类腺苷系统对动机的贡献提供了一个起点。